PEOPLE - Myriad Genetics (US) elects board member:
This article was originally published in Clinica
Salt Lake City, Utah-based Myriad Genetics, a biopharmaceutical organisation specialising in the use of proteomic and genomic technologies to create medical, diagnostic and therapeutic products, has elected Dennis Langer to its board of directors, effective May 1. Dr Langer is president of Dr Reddy's Laboratories, a global pharmaceutical company based in India. Prior to this post, he served at GlaxoSmithKline for ten years.